Drawing for KOMIPHARM

USPTO serial 79172263

KOMIPHARM

Reviewed by CopyMark Law Group

Reg. 5084132Status 404
Filing date
Status date
Registration date
Nov 22, 2016
Examiner
SCHWAB, MATTHEW DAVID
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KOMIPHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yoon S. Ham

Yoon S. Ham Hauptman Ham, LLP2318 Mill RoadSuite 1400Alexandria, VA 22314

Goods and services

ClassDescriptionStatusFirst use
005Disinfectants for hygiene purposes; Veterinary preparations, namely, pain relief medication, medication for treatment of intestinal bacteria, antioxidants; Deodorizing preparations for household, commercial or industrial use for pet litter boxes, carpets; Household deodorant; Insecticides; Germicides; Insect repellents; Medicines for veterinary purposes, namely, medicines for treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Antibiotic preparations; Chemotherapeutics; Tumor suppressing agents; Pharmaceutical preparations acting on the central nervous system; Cardiovascular pharmaceutical preparations; Pharmaceutical agents affecting metabolism; Chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation associated with cancer, the treatment of cancer, the treatment of leukemia and lymphoma, the treatment of metastatic neoplastic diseases, the treatment of brain tumors, cancer stem cell-targeted and drug resistant cancer therapy, the treatment of urogenital cancer and its metastasis; Biological preparations for the treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosisSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 30, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Nov 30, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
May 23, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 11, 2024INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Feb 20, 2024INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 19, 2024INPCINVALIDATION PROCESSED—
Feb 9, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 9, 2023C71TCANCELLED SECTION 71—
Nov 22, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 25, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 7, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 7, 2017FIMPFINAL DISPOSITION PROCESSED—
Feb 22, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 22, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 16, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 6, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 6, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 17, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 17, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 17, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 2, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 26, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 22, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jul 22, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 22, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 22, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 21, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2016GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 21, 2016GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 21, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 28, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 28, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 23, 2016ALIEASSIGNED TO LIE—
Mar 10, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 9, 2015RFNTREFUSAL PROCESSED BY IB—
Sep 18, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 18, 2015RFRRREFUSAL PROCESSED BY MPU—
Sep 18, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 17, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 16, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2015DOCKASSIGNED TO EXAMINER—
Sep 14, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 10, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance